Skip to content
Search

Latest Stories

Submit Guest Post

India likely to surpass China in COVID-19 tally; total cases over 78,000

THE total number of COVID-19 cases in India has jumped by 3,722 in past 24 hours, increasing the total number of confirmed cases to 78,003 on Thursday (14), said the health ministry.

The country is likely to surpass China in total number of cases soon. The overall confirmed cases on the mainland had reached 82,929, including 101 patients who were still being treated. Overall, the death toll in China stood at 4,633, according to official data.


India's death toll has risen to 2,549 while 26,234 have been cured of the virus, said the ministry. As many as 134 deaths were registered in the past 24 hours. The total active coronavirus cases in the country were at 49,219, while 26,234 have been cured of the virus.

According to the health ministry data, Maharashtra has the highest number of coronavirus cases at 25,922, followed by Gujarat (9,267), Tamil Nadu (9,227), Delhi (7,998), Rajasthan (4,328), Madhya Pradesh (4,173) and Uttar Pradesh (3,729).

Meanwhile, finance minister Nirmala Sitharaman unveiled the first installment of the economic package, as announced earlier by prime minister Narendra Modi.

A decision on the future course of action on the lockdown is expected in the next few days, though PM Modi has said that the 'fourth' phase would be different from the third one, in which some relaxations were already given.

Indian government has claimed that the testing capacity has increased to 100,000 tests per day.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weight loss pill

Foundayo is the latest GLP-1 treatment to receive UK approval in tablet form

Representational image: iStock

UK becomes first European nation to approve new weight-loss pill, but NHS access is still pending

  • The UK is the first European country to approve Eli Lilly’s Foundayo pill.
  • The tablet is taken once a day without food or water restrictions.
  • NHS availability will depend on a separate NICE assessment.

The UK has become the first European nation to approve a new daily weight-loss pill, giving patients another option beyond the injectable treatments that have dominated the GLP-1 market.

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly’s orforglipron, sold under the brand name Foundayo, on August 10 for weight management and to improve blood sugar control in adults with type 2 diabetes.

Keep ReadingShow less